Clinical Trials Logo

Discogenic Back Pain clinical trials

View clinical trials related to Discogenic Back Pain.

Filter by:
  • None
  • Page 1

NCT ID: NCT03644251 Terminated - Clinical trials for Discogenic Back Pain

FLO for Discogenic Pain

Start date: August 13, 2018
Phase: N/A
Study type: Interventional

Discogenic pain is pain originating from a damaged vertebral disc and be caused by inflammation, dehydration of the nucleus pulposus, decreased disc height, annular tears and impaired mechanical function of the disc.Non-operative treatment may include traction, steroid therapy, methylene blue injection and ablative therapy. However, there are few high quality studies evaluating these treatments for reducing discogenic low back pain and most clinical trials failed to detect significant differences between treatments and placebo therapies. Hence, there remains an unmet clinical need.

NCT ID: NCT02089139 Terminated - Clinical trials for Discogenic Back Pain

Treatment of Discogenic Back Pain

EGID
Start date: May 2014
Phase: N/A
Study type: Interventional

Discogenic low back pain is the most common form of chronic low back pain. Its diagnosis is mainly based on MR imaging, showing MODIC I or II changes in patients with concordant symptomatology. The treatment of discogenic low back pain is nevertheless difficult: intradiscal therapies (corticosteroids, methylene blue, radiofrequency) have a limited efficacy, and surgical procedures (arthrodesis or disc replacement) are a final recourse with notable risk of side-effects. In this study, the efficacy of intradiscal injection of gelified ethanol (DiscoGel) in patients with disabling discogenic pain is assessed.